Complex analysis of the p53 tumor suppressor in lung carcinoma (original) (raw)

EXPRESSION OF p53 IN HUMAN BREAST CANCER

Veaceslav Fulga

Biological Markers in Fundamental and Clinical Medicine (collection of abstracts), 2017

View PDFchevron_right

P53: A Molecular Marker for the Detection of Cancer

Nikolina Vlatkovic

Expert Opinion on Medical Diagnostics, 2008

View PDFchevron_right

P53-FAMILY Proteins and Their Regulators: Hubs and Spokes in Tumor Suppression

Andrea Lunardi

Cell Death & Differentiation, 2010

View PDFchevron_right

P53 Immunostaining is Correlated with Reduced Survival and is Not Correlated with Gene Mutations in Resected Pulmonary Large Cell Carcinomas

teresa takagaki

Brazilian Journal of Medical and Biological Research, 2007

View PDFchevron_right

P53 in Breast Cancer: Mutation and Countermeasures

Sumit Kumar

Frontiers in Bioscience, 2007

View PDFchevron_right

Stage-specific sensitivity to p53 restoration during lung cancer progression

Christopher Cashman

Nature, 2010

View PDFchevron_right

p53 Gene Replacement for Cancer&Interactions with DNA Damaging Agents

Susan Grammer

Acta Oncologica, 2001

View PDFchevron_right

Mutations in p53, p53 protein overexpression and breast cancer survival

Tara Kalra

Carolina Digital Repository (University of North Carolina at Chapel Hill), 2009

View PDFchevron_right

Supplementary Table 2 from Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression

Dan Longo

2023

View PDFchevron_right

Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non–small cell lung cancer

Wilfried Eberhardt

The Journal of Thoracic and Cardiovascular Surgery, 2008

View PDFchevron_right

Analysis of p53 Serum Antibodies in Patients With Head and Neck Squamous Cell Carcinoma

Patrick Marandas

JNCI Journal of the National Cancer Institute, 1996

View PDFchevron_right

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

N. Soufir

British Journal of Cancer, 2001

View PDFchevron_right

p53 Status Identifies Two Subgroups of Triple-negative Breast Cancers with Distinct Biological Features

Patrizia Querzoli

Japanese Journal of Clinical Oncology, 2011

View PDFchevron_right

Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients

Frede Donskov

Journal of Immunotherapy, 2011

View PDFchevron_right

Identification of R249 mutation in P53 Gene in tumoral tissue of tongue cancer

Mohammad Lajevardi

International Journal of Preventive Medicine, 2019

View PDFchevron_right

P53 is Essential for Chemotherapy-Induced Hair Loss

Andrei Gudkov

2000

View PDFchevron_right

p53 Expression and cell proliferation in squamous cell carcinomas of the head and neck

Björn Zackrisson

Cancer, 1995

View PDFchevron_right

Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes

Anindita Das

Oncogene, 2004

View PDFchevron_right

Computational protein chemistry of p53 and p53 peptides

Matthew Pincus

Frontiers in Bioscience, 2004

View PDFchevron_right

P53 at the Crossroads Between Cancer and Neurodegeneration

Cristina Lanni

Free Radical Biology and Medicine, 2012

View PDFchevron_right

Aberrant P53 Expression and the Development of Gallbladder Carcinoma and Adenoma

Kung-Kai Kuo

The Kaohsiung Journal of Medical Sciences, 2006

View PDFchevron_right

P53 Re-Expression Inhibits Proliferation and Restores Differentiation of Human Thyroid Anaplastic Carcinoma Cells

S. Filetti

Oncogene, 1997

View PDFchevron_right

Translational approaches targeting the p53 pathway for anti-cancer therapy

Frank Essmann

British Journal of Pharmacology, 2012

View PDFchevron_right

Expression of prostate specific antigen (PSA) is negatively regulated by p53

Elena Feinstein

Oncogene, 2002

View PDFchevron_right

P53 Mutations Are Infrequent and Do Not Correlate with the Metastatic Potential of Human-Melanoma Cells

Mordechai Gutman

International Journal of Oncology, 1993

View PDFchevron_right

P53 Nuclear Accumulation as an Early Indicator of Lethal Prostate Cancer

John Grygiel

British Journal of Cancer, 2019

View PDFchevron_right

Repair or perish – the role of p53 protein in a cell’s life

Barbara Pieńkowska-grela

Nowotwory. Journal of Oncology, 2019

View PDFchevron_right

Faculty of 1000 evaluation for Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations

Martine Roussel

F1000 - Post-publication peer review of the biomedical literature, 2007

View PDFchevron_right

A pilot study on risk factors and p53 gene expression in colorectal cancer

Peter Söderkvist

British Journal of Cancer, 1996

View PDFchevron_right

Evaluating Drosophila p53 as a Model System for Studying Cancer Mutations

Merav Shmueli

Journal of Biological Chemistry, 2012

View PDFchevron_right

Comparative p53 mutational analysis of multiple primary cancers of the upper aerodigestive tract

Ulysses Ribeiro

Surgery, 1996

View PDFchevron_right

P1.02-028 Pathways Involved in Early Stage Lung Cancers

Vilde Haakensen

Journal of Thoracic Oncology, 2017

View PDFchevron_right

p63 and p73, members of the p53 gene family, transactivate PKCδ

alessandro terrinoni

Biochemical Pharmacology, 2006

View PDFchevron_right

Prognostic Significance of p53 Protein Expression in Early Gastric Cancer

Heitor S P de Souza

Pathology & Oncology Research, 2010

View PDFchevron_right

Tumor Suppressor Protein p53 Recruits Human Sin3B

leena vig

2011

View PDFchevron_right